Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun;46(6):692-698.
doi: 10.1016/j.semarthrit.2016.09.001. Epub 2016 Sep 13.

Elevated BMI and antibodies to citrullinated proteins interact to increase rheumatoid arthritis risk and shorten time to diagnosis: A nested case-control study of women in the Nurses' Health Studies

Sara K Tedeschi  1 , Jing Cui  2 , Elizabeth V Arkema  3 , William H Robinson  4 , Jeremy Sokolove  4 , Nithya Lingampalli  4 , Jeffrey A Sparks  2 , Elizabeth W Karlson  2 , Karen H Costenbader  2
Affiliations

Elevated BMI and antibodies to citrullinated proteins interact to increase rheumatoid arthritis risk and shorten time to diagnosis: A nested case-control study of women in the Nurses' Health Studies

Sara K Tedeschi et al. Semin Arthritis Rheum. 2017 Jun.

Abstract

Objective: Overweight/obesity and anti-citrullinated protein antibodies (ACPA) increase rheumatoid arthritis (RA) risk. We investigated the relationship between body mass index (BMI) and ACPA, tested for an interaction between BMI and ACPA for RA risk, and examined effects of BMI and ACPA on time to RA diagnosis.

Design: Within the Nurses' Health Studies, blood samples were collected before diagnosis from medical record-confirmed incident RA cases and matched controls. Multiplex assays measured 7 ACPA subtypes (biglycan, clusterin, enolase, fibrinogen, histone 2A, histone 2B, and vimentin). Logistic regression analyses tested the association of BMI and ACPA and for a multiplicative interaction between BMI groups (≥25 vs. <25kg/m2) and ACPA positivity (≥2 vs. <2 subtypes), adjusting for age, smoking, alcohol use, and HLA-shared epitope. In case-only analyses, log-rank tests compared time from blood draw to RA onset by cross-classified BMI/ACPA status.

Results: Among 255 pre-RA cases and 778 matched controls, 15.7% vs. 2.1% (p<0.001) had ≥2 ACPA and 49.4% vs. 40.2% (p<0.01) were overweight/obese. Continuous BMI was not associated with presence of ≥2 ACPA [OR per kg/m2 unit BMI: 1.03 (95% CI: 0.97-1.09)]. However, there was a multiplicative interaction between elevated BMI and the presence of ≥2 ACPA for RA risk (p = 0.027). Women with BMI≥25kg/m2 and ≥2 ACPA had OR 22.7 (95% CI: 6.64-77.72) for RA. Median time to RA differed by BMI/ACPA group (overall log-rank p<0.001) and was shortest among women with ≥2 ACPA and BMI≥25kg/m2 [45.0 months, IQR: 17.5-72.5] and longest in women with <2 ACPA and BMI<25kg/m2 [125.0 months, IQR: 72.0-161.0] (pairwise log-rank p = 0.002).

Conclusion: Elevated BMI and presence of ACPA interacted to increase RA risk. Time to RA onset was shortest among overweight/obese women with ≥2 ACPA.

Keywords: ACPA; Autoantibodies; Obesity; Rheumatoid arthritis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Multiplicative interaction between ACPA status (≥2 ACPA) and BMI ≥25 on risk of RA among 1033 women (NHS and NHSII) in a nested case-control study of RA
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against Cyclic Citrullinated Peptide and Iga Rheumatoid Factor Predict the Development of Rheumatoid Arthritis. Arthritis Rheum. 2003;48(10):2741–9. - PubMed
    1. Nielen MM, van Schaardenburg D, Reesink HW, Twisk JW, van de Stadt RJ, van der Horst-Bruinsma IE, et al. Simultaneous Development of Acute Phase Response and Autoantibodies in Preclinical Rheumatoid Arthritis. Ann Rheum Dis. 2006;65(4):535–7. - PMC - PubMed
    1. Chibnik LB, Mandl LA, Costenbader KH, Schur PH, Karlson EW. Comparison of Threshold Cutpoints and Continuous Measures of Anti-Cyclic Citrullinated Peptide Antibodies in Predicting Future Rheumatoid Arthritis. J Rheumatol. 2009;36(4):706–11. - PMC - PubMed
    1. Karlson EW, Chibnik LB, Tworoger SS, Lee IM, Buring JE, Shadick NA, et al. Biomarkers of Inflammation and Development of Rheumatoid Arthritis in Women from Two Prospective Cohort Studies. Arthritis Rheum. 2009;60(3):641–52. - PMC - PubMed
    1. Kokkonen H, Mullazehi M, Berglin E, Hallmans G, Wadell G, Ronnelid J, et al. Antibodies of Igg, Iga and Igm Isotypes against Cyclic Citrullinated Peptide Precede the Development of Rheumatoid Arthritis. Arthritis Res Ther. 2010;13(1):R13. - PMC - PubMed

Publication types

Substances